The effect of melatonin on sleep disturbances of hemodialysis patients.

Not Applicable

• Conditions: Condition 1: Chronic Renal Failure. Condition 2: Sleep disturbance.; End-stage renal disease; Nonorganic sleep disorders

• Registration Number: IRCT201108077253N1
• Lead Sponsor: Office of Vice Chancellor for Research of Arak Medical Science University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

ESRD patients undergoing hemodialysis >3 months with PSQI score equal or >5/ age:18-85/capable of giving informed consent
exclusion: severe allergy to melatonin/unstable angina or hearth failure class 4/ pregnancy or breast feeding/ severe medical or psychological disease/history of melatonin consumption

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: Before intervention and 6th and 12th week of intervention. Method of measurement: PSQI questionnaire.

Secondary Outcome Measures

Name	Time	Method
Serum lipids. Timepoint: At study beginning, 6 and 12 weeks. Method of measurement: Valiasr lab.;Erythropoitin dosages. Timepoint: 0, 6th and 12th weeks. Method of measurement: Providing from dialysis sheets review.;Serum hemoglobin levels. Timepoint: 0, 6th and 12th weeks. Method of measurement: Valiasr lab.